These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27106073)

  • 1. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects.
    Benedetti F; Carlino E; Piedimonte A
    Lancet Neurol; 2016 Jun; 15(7):736-747. PubMed ID: 27106073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The placebo-nocebo response: controversies and challenges from clinical and research perspective.
    Jakovljevic M
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):333-41. PubMed ID: 24393653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can knowledge of Placebo and Nocebo Mechanisms Help Improve Randomized Clinical Trials?
    Carlino E; Vase L
    Int Rev Neurobiol; 2018; 138():329-357. PubMed ID: 29681333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Role of Placebo: Evolution of a New Paradigm in Understanding Research and Clinical Practice.
    Manchikanti L; Boswell MV; Kaye AD; Helm Ii S; Hirsch JA
    Pain Physician; 2017 Jul; 20(5):363-386. PubMed ID: 28727700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking Clinical Trials and Personalized Medicine with Placebogenomics and Placebo Dose.
    Özdemir V; Endrenyi L
    OMICS; 2021 Jan; 25(1):1-12. PubMed ID: 33305994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocebo Responses in Brain Diseases: A Systematic Review of the Current Literature.
    Zis P; Mitsikostas DD
    Int Rev Neurobiol; 2018; 139():443-462. PubMed ID: 30146057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo and nocebo effects in randomized controlled trials: the implications for research and practice.
    Sanderson C; Hardy J; Spruyt O; Currow DC
    J Pain Symptom Manage; 2013 Nov; 46(5):722-30. PubMed ID: 23523360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of methodological issues of clinical trials in multiple sclerosis.
    Montalban X
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S35-42. PubMed ID: 22206765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing the power of placebos in movement disorders: Insights from Parkinson's disease in clinical research and practice.
    Mestre TA; Shamy M; Benedetti F; Lang AE
    Mov Disord; 2018 Aug; 33(8):1195-1203. PubMed ID: 30145820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons to be learned from placebo arms in psychopharmacology trials.
    Doering BK; Rief W; Petrie KJ
    Handb Exp Pharmacol; 2014; 225():273-90. PubMed ID: 25304537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo and nocebo responses in drug trials of epilepsy.
    Zaccara G; Giovannelli F; Schmidt D
    Epilepsy Behav; 2015 Feb; 43():128-34. PubMed ID: 25703333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain.
    Dworkin RH; Katz J; Gitlin MJ
    Neurology; 2005 Dec; 65(12 Suppl 4):S7-19. PubMed ID: 16385107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice.
    Schedlowski M; Enck P; Rief W; Bingel U
    Pharmacol Rev; 2015 Jul; 67(3):697-730. PubMed ID: 26126649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature of the placebo and nocebo effect in relation to functional neurologic disorders.
    Carlino E; Piedimonte A; Benedetti F
    Handb Clin Neurol; 2016; 139():597-606. PubMed ID: 27719874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo and nocebo effects: a complex interplay between psychological factors and neurochemical networks.
    Frisaldi E; Piedimonte A; Benedetti F
    Am J Clin Hypn; 2015 Jan; 57(3):267-84. PubMed ID: 25928679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo and nocebo effects in the neurological practice.
    Bittar C; Nascimento OJ
    Arq Neuropsiquiatr; 2015 Jan; 73(1):58-63. PubMed ID: 25608129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug*placebo interaction effect may bias clinical trials interpretation: hybrid balanced placebo and randomized placebo-controlled design.
    Hammami MM; Hammami S; Al-Swayeh R; Al-Gaai E; Farah FA; De Padua SJ
    BMC Med Res Methodol; 2016 Nov; 16(1):166. PubMed ID: 27899067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nocebo effect as a source of bias in the assessment of treatment effects.
    Wartolowska K
    F1000Res; 2019; 8():5. PubMed ID: 31354941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.